Senator Cassidy Discusses Impact of Trump's Tariffs on Generic Drug Safety
Senator Bill Cassidy of Louisiana has commented on President Trump's proposed tariffs on imported generic drugs, suggesting that while they may increase prices, they could also enhance national security by reducing reliance on foreign drug production. Trump has proposed giving generic drug companies two years to relocate production to the U.S., after which tariffs would be imposed on imports. Cassidy, a key figure in health policy, argues that the U.S. should not depend on China for critical drug components, as this could pose risks if geopolitical tensions rise.